CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes
NCT ID: NCT02030704
Last Updated: 2018-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2008-02-29
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sequential Coronary CT-angiography and Biomarkers
NCT02394262
Detection and Significance of Heart Injury in ST Elevation Myocardial Infarction.
NCT02072850
Intracoronary Thrombus Detection by Magnetic Resonance Imaging
NCT02776657
Risk Evaluation by COronary Imaging and Artificial intelliGence Based fuNctIonal analyZing tEchniques - III
NCT06793774
Biomarkers and Cardiac CT
NCT02381301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atherosclerotic Plaque
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* acute coronary syndromes
* cardiomyopathies
* moderate or severe valvular disease
* elevated serum creatinine (\>1.5 mg/dl)
* history or ECG signs of previous myocardial infarction
* severe iodine allergy.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Semmelweis University Heart and Vascular Center
OTHER
Heidelberg University
OTHER
University Hospital Heidelberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GKorosoglou
Prof. Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Grigorios Korosoglou, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
University of Heidelberg, Department of Cardiology, Heidelberg, Germany.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Heidelberg, Department of Cardiology
Heidelberg, Baden-Wurttemberg, Germany
MTA-SE Lendület Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University
Budapest, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Korosoglou G, Mueller D, Lehrke S, Steen H, Hosch W, Heye T, Kauczor HU, Giannitsis E, Katus HA. Quantitative assessment of stenosis severity and atherosclerotic plaque composition using 256-slice computed tomography. Eur Radiol. 2010 Aug;20(8):1841-50. doi: 10.1007/s00330-010-1753-3. Epub 2010 Mar 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HDCCTA01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.